Your session is about to expire
← Back to Search
Breast MRI Imaging Techniques for Breast Cancer
N/A
Waitlist Available
Led By A. Bapsi Chakravarthy, MD
Research Sponsored by Vanderbilt-Ingram Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subjects with known or suspected breast disease
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 months
Awards & highlights
Study Summary
This trial is studying how well breast MRI works in diagnosing and predicting treatment response in women with breast cancer or those at high risk for the disease.
Eligible Conditions
- Breast Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You have a known or suspected breast condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ on-study date and at 6 months, up to 4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on-study date and at 6 months, up to 4 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of advanced, quantitative, multi-parametric magnetic resonance imaging (MRI) methods for characterizing breast tumors to develop potential surrogate imaging markers for diagnosis and prediction of treatment response
Secondary outcome measures
Correlation of biochemical data obtained from magnetic resonance analysis with clinical, radiological, and pathological findings
Establishment of an imaging data bank
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Participants with breast cancerExperimental Treatment3 Interventions
Group II: Participants without breast cancerActive Control3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
dynamic contrast-enhanced magnetic resonance imaging
2006
Completed Phase 2
~450
magnetic resonance spectroscopic imaging
2010
N/A
~230
diffusion-weighted magnetic resonance imaging
2013
Completed Phase 1
~730
Find a Location
Who is running the clinical trial?
Vanderbilt-Ingram Cancer CenterLead Sponsor
213 Previous Clinical Trials
60,724 Total Patients Enrolled
27 Trials studying Breast Cancer
6,385 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,915,437 Total Patients Enrolled
938 Trials studying Breast Cancer
1,543,124 Patients Enrolled for Breast Cancer
A. Bapsi Chakravarthy, MDPrincipal InvestigatorVanderbilt-Ingram Cancer Center
11 Previous Clinical Trials
4,340 Total Patients Enrolled
7 Trials studying Breast Cancer
4,203 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a known or suspected breast condition.
Research Study Groups:
This trial has the following groups:- Group 1: Participants with breast cancer
- Group 2: Participants without breast cancer
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research program presently open for enrollment?
"According to information located on clinicaltrials.gov, this medical trial is not looking for participants at present; the first posting was dated March 1st 2006 and its last update was recorded November 22nd 2021. That said, there are 2602 other trials that are currently enrolling patients."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger